文献速递自身炎症与 IgG4 相关病

慢性复发性多灶性骨髓炎患者的血清蛋白质组谱

Serum proteomic profiles of patients with chronic recurrent multifocal osteomyelitis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

本研究采用液相色谱-质谱联用技术对11例慢性复发性多灶性骨髓炎(CRMO)患者(活动期5例、非活动期6例)及4例无炎症性疾病对照儿童的血清进行蛋白质组学分析,发现活动期CRMO患者较对照组有19种蛋白上调和41种蛋白下调,轴突导向是上调蛋白最富集的通路;与非活动期相比,36种蛋白(含11种角蛋白)上调并富集于中间丝组织类别;布洛芬治疗患者中Rho GTP酶通路相关蛋白下调。作者认为这些上调蛋白可作为疾病诊断和活动度的生物标志物,并期待该研究有助于深入理解CRMO病理生理及发现潜在新治疗靶点。

要点

  • 活动期CRMO患者血清较对照组有19种蛋白上调和41种蛋白下调。
  • 轴突导向是活动期CRMO上调蛋白最富集的通路,其次为中性粒细胞脱颗粒和MAPK级联调控。
  • 与非活动期相比,36种蛋白(含11种角蛋白)在活动期上调并富集于中间丝组织类别。

核心结论

  • 蛋白质组学分析鉴定出急性CRMO患者血清中的上调蛋白,这些蛋白可作为疾病诊断和活动度的生物标志物。
  • 作者期待该研究有助于深入理解CRMO的病理生理,进而有助于发现潜在的新治疗靶点。

研究设计与样本

  • 研究采用液相色谱-质谱联用技术对11例CRMO患者(活动期5例、非活动期6例)的血清进行蛋白质组学分析,并以4例无炎症性疾病儿童的血清作为对照。
  • 研究进行了通路分析,以识别活动期CRMO患者中上调和下调的蛋白。

主要发现

  • 与对照组相比,活动期CRMO患者分别有19种蛋白上调和41种蛋白下调。
  • 通路与过程富集分析显示,轴突导向是活动期CRMO上调蛋白最富集的类别,其次为中性粒细胞脱颗粒和丝裂原活化蛋白激酶级联调控。
  • 与非活动期CRMO患者相比,36种蛋白(包括11种角蛋白)上调并高度富集于中间丝组织类别。
  • 布洛芬治疗患者中Rho GTP酶通路相关蛋白下调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disease characterized by sterile bone inflammation; however, its pathophysiology is poorly understood. Thus, this study aimed to characterize the serum proteomic profiles of patients with CRMO to better understand the molecular mechanisms underpinning CRMO pathogenesis. METHODS: Proteomic profiling of the sera collected from 11 patients with CRMO (5 patients were in active phase, 6 were in inactive phase) was conducted using liquid chromatography-mass spectrometry. Sera from four children without inflammatory diseases were used as controls. Pathway analysis was performed to identify the upregulated and downregulated proteins in patients with active CRMO. RESULTS: Compared with the control group, 19 and 41 proteins were upregulated and downregulated, respectively, in patients with active CRMO. Pathway and process enrichment analyses revealed that axon guidance was the most enriched category of upregulated proteins in patients with active CRMO, followed by neutrophil degranulation and mitogen-activated protein kinase cascade regulation. In comparison to patients with inactive CRMO, 36 proteins, including 11 keratin proteins, were upregulated and highly enriched in the intermediate filament organization category. Rho GTPase pathway-related proteins were downregulated in ibuprofen-treated patients. CONCLUSION: Proteomic analysis identified upregulated proteins in the sera of patients with acute CRMO. These proteins can be used as biomarkers for disease diagnosis and activity. Furthermore, we anticipate that this study will contribute to a deeper understanding of the pathophysiology of CRMO, which, in turn, will contribute to the discovery of potential novel therapeutic targets.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kawada JI, Yamaguchi M, Haruta K, et al. Serum proteomic profiles of patients with chronic recurrent multifocal osteomyelitis. Rheumatology (Oxford). 2025. PMID: 38775453. doi:10.1093/rheumatology/keae301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。